Robert A. Wood

GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management

S. Halken, E. Angier, G. Lack, 2024, Clinical and translational allergy.

Omalizumab for the Treatment of Multiple Food Allergies.

S. Sicherer, B. Lanser, C. Keet, 2024, The New England journal of medicine.